Medulloblastoma

Medulloblastoma is a malignant brain tumor that begins in the cerebellum and can spread through cerebrospinal fluid. Molecular subgroup, age and disease spread help determine risk and treatment.

Other names and abbreviations

MB, cerebellar PNET, posterior fossa embryonal tumor, Cerebellar primitive neuroectodermal tumour (obsolete umbrella term), medulloblastoma molecular groups

In short

  • Medulloblastoma is a brain cancer that starts in the cerebellum and can spread through the fluid around the brain and spinal cord, mostly in children.
  • Treatment uses surgery, chemotherapy and radiation matched to age and risk, and some plans for young children use strong chemotherapy to delay or reduce radiation.
  • In some plans for young children or for cancer that comes back, high-dose chemotherapy is followed by a return of the patient's own stem cells, not a donor's.
Jump to a section

Underlined words open a short explanation. See all terms

Where transplant fits

with is used in selected young-child or protocols. It returns the patient’s own cells and is not a routine indication for an unrelated donor.

Treatment depends on the exact diagnosis, disease stage, prior treatment and the person’s health.

Key facts

Who it affects
Medulloblastoma mainly affects children but can occur in adults.
Usual treatment
Treatment uses surgery with chemotherapy and age- and risk-adapted radiation. In younger children, some protocols use intensive chemotherapy to delay or reduce radiation exposure; recurrent disease needs an individualized plan.
Cells used in a transplant
The patient’s own collected blood-forming cells for autologous stem cell rescue, when that procedure is appropriate.
Where a donor fits
Limited transplant role

Support for patients and families

These independent organizations offer information and support. JBF is not affiliated with them.

Questions to bring to your care team

  • What is the exact name of the diagnosis or subtype, and what does it mean for treatment?
  • What is the goal of each treatment you are suggesting?
  • What would make a transplant worth considering later on?
  • Are there clinical trials that might fit?
  • Where can our family find support during treatment?

Supporting someone with a diagnosis

Sources and further reading

  1. Childhood Medulloblastoma and Other CNS Embryonal Tumors Treatment (PDQ)
    NCI, Accessed 2026-09-05
  2. Indications for haematopoietic cell transplantation and CAR-T: 2025 EBMT practice recommendations
    EBMT / Bone Marrow Transplantation, Accessed 2026-09-05
  3. Stem Cell and Bone Marrow Transplants for Cancer
    NCI, Accessed 2026-09-05

Other patients are waiting for a match.

Most people with medulloblastoma are treated without a registry donor. Many people with other blood cancers and blood disorders need a donor who is a stranger.

Join the registry

JBF points you to the official registry that serves your country. It explains who can join and what donation involves.

Help a family run a drive

If someone you love needs a donor, a registration drive can add many potential donors at once, for them and for others.

Support this work

Gifts to the Jada Bascom Foundation support donor-awareness education like this guide, community outreach, drive planning and referrals to official registries.

Donate to JBF

We respect your privacy. Unsubscribe anytime.

Keep learning